Charles River Laboratories, a Wilmington, Mass., pharma services giant, is closing a Skokie office that will result in the ...

In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report).

In a report released yesterday, Charles Rhyee from TD Cowen maintained a Hold rating on Charles River Labs (CRL – Research Report), with ...

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

The Wilmington-based contract research organization offered new details in its third-quarter earnings about its previously-announced restructuring plans, including the extent of layoffs and site ...

WILMINGTON, Mass., November 11, 2024--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the UBS Global Healthcare Conference on ...

Charles River management believes that supplementary non-GAAP financial measures provide useful information to allow investors to gain a meaningful understanding of our core operating results and ...

Charles River Laboratories International Inc (NYSE:CRL) exhibits resilience despite a challenging market environment. Strategic acquisitions and a diversified service portfolio position CRL for ...

Charles River Laboratories Intl ( (CRL)) has released its Q3 earnings. Here is a breakdown of the information Charles River Laboratories Intl presented to its investors. Charles River Laboratories ...

A group of over 80 Canadian academics is urging the federal government to halt the importation of endangered macaque monkeys ...

Please stand by, we’re about to begin. Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories Third Quarter 2024 Earnings Conference Call. This call is ...